Colossal Biosciences has successfully reconstructed the Tasmanian Tiger genome with 99.99% accuracy, marking a significant step towards de-extinction efforts. The CEO notes, "We have not publicly set a date for the thylacine but as our announcement today shows, the team is making significant progress across many of the core research areas." These advances highlight the potential to resurrect species that were lost comparatively recently.
In a major breakthrough, researchers created the most complete Tasmanian Tiger genome, filling 45 gaps in its DNA sequence. They used exceptionally preserved specimens, and Dr. Beth Shapiro, Colossal's chief science officer, emphasized, "The thylacine samples used for our new reference genome are among the best preserved ancient specimens my team has worked with.", showcasing the rarity and quality of the samples that enable groundbreaking research.
Collection
[
|
...
]